TRIUS THERAPEUTICS, INC. and , As Warrant Agent FORM OF DEBT SECURITIES WARRANT AGREEMENT Dated As OfWarrant Agreement • August 31st, 2012 • Trius Therapeutics Inc • Pharmaceutical preparations • New York
DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between TRIUS THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
TRIUS THERAPEUTICS, INC., Issuer AND [Trustee], Trustee INDENTURE Dated as of [ ], 20 Subordinated Debt SecuritiesTrius Therapeutics Inc • August 31st, 2012 • Pharmaceutical preparations • New York
INDENTURE, dated as of [ ], 20 , among TRIUS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
TRIUS THERAPEUTICS, INC. and , As Warrant Agent FORM OF COMMON STOCK WARRANT AGREEMENT Dated As OfWarrant Agreement • August 31st, 2012 • Trius Therapeutics Inc • Pharmaceutical preparations • New York
COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between TRIUS THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
TRIUS THERAPEUTICS, INC. and , As Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated As OfPreferred Stock Warrant Agreement • August 31st, 2012 • Trius Therapeutics Inc • Pharmaceutical preparations • New York
PREFERRED STOCK WARRANT AGREEMENT (the “Agreement”), dated as of between TRIUS THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
